Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: Taiwan Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20041
20053
20066
20077
20085
200911
20107
20116
20124
20139
20149
20155
20164
20178
20187
20199
20204
20214
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed118

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kaohsiung Medical University Chung-Ho Memorial Hospital12
Bayer11
National Taiwan University Hospital11
Bristol-Myers Squibb7
Hoffmann-La Roche6
Eli Lilly and Company5
Novartis Pharmaceuticals5
Merck Sharp & Dohme LLC4
Chang Gung Memorial Hospital3
GlaxoSmithKline3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular118
Liver Neoplasms29
Neoplasms8
Carcinoma, Non-Small-Cell Lung5
Carcinoma4
Cholangiocarcinoma4
Hepatitis B4
Ovarian Neoplasms4
Stomach Neoplasms4
Small Cell Lung Carcinoma3

Trials

Showing 1 to 25 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.